Rep. Gilbert Ray Cisneros, Jr. Sells Align Technology, Inc. (NASDAQ:ALGN) Stock

Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of Align Technology, Inc. (NASDAQ:ALGN). In a filing disclosed on March 06th, the Representative disclosed that they had sold between $1,001 and $15,000 in Align Technology stock on February 26th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of Sterling Infrastructure NASDAQ: STRL on 3/3/2025.
• Purchased $1,001 - $15,000 in shares of Hillman Solutions NASDAQ: HLMN on 3/3/2025.
• Sold $1,001 - $15,000 in shares of Ford Motor NYSE: F on 2/26/2025.
• Purchased $1,001 - $15,000 in shares of Uber Technologies NYSE: UBER on 2/26/2025.
• Sold $15,001 - $50,000 in shares of UnitedHealth Group NYSE: UNH on 2/26/2025.
• Purchased $15,001 - $50,000 in shares of Microsoft NASDAQ: MSFT on 2/26/2025.
• Sold $1,001 - $15,000 in shares of General Motors NYSE: GM on 2/26/2025.
• Purchased $1,001 - $15,000 in shares of Tesla NASDAQ: TSLA on 2/26/2025.
• Sold $1,001 - $15,000 in shares of Akamai Technologies NASDAQ: AKAM on 2/26/2025.
• Sold $1,001 - $15,000 in shares of Danaher NYSE: DHR on 2/26/2025.

Align Technology Price Performance

Shares of ALGN stock traded down $5.97 during mid-day trading on Monday, hitting $167.78. The company had a trading volume of 59,360 shares, compared to its average volume of 762,770. The stock's 50 day moving average price is $208.02 and its 200-day moving average price is $221.19. Align Technology, Inc. has a 52-week low of $167.32 and a 52-week high of $335.40. The company has a market capitalization of $12.35 billion, a P/E ratio of 29.91, a P/E/G ratio of 2.24 and a beta of 1.69.

Remove Ads

Align Technology (NASDAQ:ALGN - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $1.96 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.43 by ($0.47). Align Technology had a net margin of 10.54% and a return on equity of 13.84%. On average, equities research analysts expect that Align Technology, Inc. will post 7.98 earnings per share for the current year.

Institutional Investors Weigh In On Align Technology

Several hedge funds and other institutional investors have recently made changes to their positions in ALGN. Impax Asset Management Group plc raised its position in Align Technology by 26.8% in the 3rd quarter. Impax Asset Management Group plc now owns 114,057 shares of the medical equipment provider's stock worth $29,007,000 after purchasing an additional 24,115 shares during the period. Crestwood Advisors Group LLC grew its stake in shares of Align Technology by 6.6% during the third quarter. Crestwood Advisors Group LLC now owns 1,000 shares of the medical equipment provider's stock valued at $254,000 after buying an additional 62 shares during the last quarter. Principal Financial Group Inc. raised its holdings in shares of Align Technology by 2.7% in the third quarter. Principal Financial Group Inc. now owns 82,020 shares of the medical equipment provider's stock worth $20,859,000 after buying an additional 2,168 shares during the period. Kornitzer Capital Management Inc. KS purchased a new stake in shares of Align Technology in the third quarter worth approximately $205,000. Finally, Portside Wealth Group LLC bought a new stake in shares of Align Technology during the 3rd quarter worth approximately $238,000. Hedge funds and other institutional investors own 88.43% of the company's stock.

Wall Street Analysts Forecast Growth

ALGN has been the topic of a number of research analyst reports. Wells Fargo & Company began coverage on Align Technology in a research report on Friday, February 14th. They issued an "overweight" rating and a $255.00 target price on the stock. Piper Sandler decreased their price objective on Align Technology from $275.00 to $270.00 and set an "overweight" rating on the stock in a report on Thursday, February 6th. Leerink Partners upgraded Align Technology from a "market perform" rating to an "outperform" rating and increased their target price for the company from $235.00 to $280.00 in a research report on Monday, January 6th. Needham & Company LLC restated a "hold" rating on shares of Align Technology in a research report on Thursday, February 6th. Finally, Leerink Partnrs raised shares of Align Technology from a "hold" rating to a "strong-buy" rating in a research note on Monday, January 6th. One research analyst has rated the stock with a sell rating, two have given a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, Align Technology has a consensus rating of "Moderate Buy" and an average price target of $269.91.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election. Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.